Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1876)
All Articles published online
|
Aug 14, 2007 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Poggio PD, Zaccanelli M, Oggionni M, Colombo S, Jamoletti C, Puhalo V. Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. World J Gastroenterol 2007; 13(30): 4096-4099 [PMID: 17696228 DOI: 10.3748/wjg.v13.i30.4096] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i30/4096.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1654620
|
| 3 |
R. Morillo Verdugo, A. Madrazo Berenguer, M.V. Gil Navarro, E. Suárez García. Tratamiento farmacológico de la hepatitis B. Farmacia Hospitalaria 2008; 32(4): 234 doi: 10.1016/S1130-6343(08)75937-3
|
| 4 |
Mamta K. Jain, Cindy L. Zoellner, Kanan Garg. Pharmacotherapy of Chronic Hepatitis B in Adults: Focus on Tenofovir Disoproxil Fumarate. Clinical Medicine. Therapeutics 2009; 1: CMT.S1161 doi: 10.4137/CMT.S1161
|
| 5 |
Susanne Beckebaum, Georgios C. Sotiropoulos, Guido Gerken, Vito R. Cicinnati. Hepatitis B and liver transplantation: 2008 update. Reviews in Medical Virology 2009; 19(1): 7 doi: 10.1002/rmv.595
|
| 6 |
Daryl T.-Y. Lau, Wissam Bleibel. Review: Current status of antiviral therapy for hepatitis B. Therapeutic Advances in Gastroenterology 2008; 1(1): 61 doi: 10.1177/1756283X08093944
|
| 7 |
Kin Seng Liem, David K. Wong, Scott Fung, Alireza Zahirieh, Colina Yim, Wayel R. Zanjir, Jordan J. Feld, Bettina E. Hansen, Harry L. A. Janssen. Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients. Journal of Viral Hepatitis 2021; 28(1): 51 doi: 10.1111/jvh.13401
|
| 8 |
E. Paintsil, Y.-C. Cheng. Reference Module in Biomedical Sciences. 2014; doi: 10.1016/B978-0-12-801238-3.02387-4
|
| 9 |
R. Morillo Verdugo, A. Madrazo Berenguer, M.V. Gil Navarro, E. Suárez García. Drugs Treatment of Hepatitis B. Farmacia Hospitalaria (English Edition) 2008; 32(4): 234 doi: 10.1016/S2173-5085(08)70045-5
|
| 10 |
Erik De Clercq. Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives. Medicinal Research Reviews 2009; 29(4): 611 doi: 10.1002/med.20153
|
| 11 |
Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts. Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections. Viruses 2010; 2(6): 1279 doi: 10.3390/v2061279
|
| 12 |
Dan-Hong Yang, Yuan-Jun Xie, Nian-Feng Zhao, Hong-Ying Pan, Ming-Wei Li, Hai-Jun Huang. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. World Journal of Gastroenterology 2015; 21(9): 2746-2753 doi: 10.3748/wjg.v21.i9.2746
|
| 13 |
Hie-Won Hann, Hee Bok Chae, Stephen R. Dunn. Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV). Hepatology International 2008; 2(2): 244 doi: 10.1007/s12072-008-9045-6
|
| 14 |
Dennis J. Cada, Terri L. Levien, Danial E. Baker. Tenofovir Disoproxil Fumarate Tablets. Hospital Pharmacy 2009; 44(2): 165 doi: 10.1310/hpj4402-165
|
| 15 |
Seng Gee Lim, Guan Huei Lee, Kieron Lim, Poh Seng Tan. Resistance is no Longer a Problem with Entecavir and Tenofovir. Current Hepatitis Reports 2013; 12(2): 96 doi: 10.1007/s11901-013-0168-4
|
| 16 |
Alice M. Jenh, Chloe L. Thio, Paul A. Pham. Tenofovir for the Treatment of Hepatitis B Virus. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2009; 29(10): 1212 doi: 10.1592/phco.29.10.1212
|
| 17 |
Lauren M Hynicka, Nancy Yunker, Punam H Patel. A Review of Oral Antiretroviral Therapy for the Treatment of Chronic Hepatitis B. Annals of Pharmacotherapy 2010; 44(7-8): 1271 doi: 10.1345/aph.1M590
|
| 18 |
Alice M Jenh, Paul A Pham. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. Expert Review of Anti-infective Therapy 2010; 8(10): 1079 doi: 10.1586/eri.10.91
|
| 19 |
Michael T. Yin, James C. M. Brust, Hong Van Tieu, Scott M. Hammer. Clinical Virology. 2009; : 217 doi: 10.1128/9781555815981.ch12
|